Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652876 | PMC |
| http://dx.doi.org/10.1136/bcr-2017-222659 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic Myelomonocytic Leukemia with Central Nervous System Involvement in a Dog.
J Am Anim Hosp Assoc
January 2025
From Veterinary Neurological Center "La Fenice," Selargius, Italy (I.T., F.T., A.G.).
An 8 yr old, male, mixed-breed dog was presented with a 2 mo history of progressive weakness, worsened in the last 2 days before examination. Neurological examination revealed ambulatory tetraparesis, ataxia, and proprioceptive deficits in all four limbs. Menace response was reduced in the right eye and discomfort was detected on neck manipulation.
View Article and Find Full Text PDFThe Synchronous Diagnosis of Multiple Myeloma (MM) and Chronic Myeloid Leukemia (CML).
Cureus
November 2024
Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA.
The synchronous presentation of chronic myeloid leukemia (CML) and multiple myeloma (MM) is extremely rare. CML is a myeloproliferative neoplasm originating from an abnormal pluripotent hematopoietic stem cell. It is associated with the - fusion gene located on the Philadelphia chromosome.
View Article and Find Full Text PDFNilotinib as an Independent Risk Factor for Stroke by Accelerated Atherosclerosis.
Cureus
November 2024
Neurology, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, IND.
Article Synopsis
- - Nilotinib, a medication for chronic myeloid leukemia, can lead to serious cardiovascular issues like atherosclerosis and arterial narrowing, especially in patients who use it long-term or at high doses.
- - A case study reported a stroke in a patient on nilotinib who had no prior stroke risk factors, highlighting potential risks of the drug despite the patient's initial safety.
- - After stopping nilotinib, the patient received treatments like antiplatelets and physiotherapy, which improved his condition, emphasizing the need for regular cardiovascular monitoring in patients on nilotinib.
Heterotopic Ossification with Intrathyroidal Extramedullary Hematopoiesis in Multifocal Papillary Thyroid Carcinoma: Histopathological Findings and Literature Review.
Int J Surg Pathol
November 2024
Department of General Surgery, Rey Juan Carlos University Hospital, Madrid, Spain.
In recent decades, there has been an increase in the identification of thyroid nodules, both benign and malignant, due to the rise in imaging studies and complementary tests. Among thyroid gland tumors, papillary thyroid carcinoma (PTC) stands out as the most prevalent. Degenerative changes, mainly in the form of nodular goiter, have been recorded, occasionally including areas of calcification and, more rarely, ossification; although the latter seldom progresses to calcinosis.
View Article and Find Full Text PDFCentral Nervous System Fungal Diseases in Children with Malignancies: A 16-Year Study from the Infection Working Group of the Hellenic Society of Pediatric Hematology Oncology.
J Fungi (Basel)
September 2024
Children & Adolescent Hematology-Oncology Unit, Second Department of Pediatrics, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
We analyzed data on pediatric invasive fungal diseases of the central nervous system (CNS-IFDs) reported by five of a total of eight Pediatric Hematology-Oncology Departments in Greece for 16 years (2007-2022). A total of twelve patients (11 boys, median age: 9.5 years, range: 2-16) were reported suffering from CNS-IFDs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!